期刊文献+

儿茶酚抑素对ST段抬高型心肌梗死患者住院期间发生心力衰竭的预测价值 被引量:18

Prognostic value of circulating catestatin levels for in-hospital heart failure in patients with acute myocardial infarction
原文传递
导出
摘要 目的评价儿茶酚抑素(catestatin,CST)对ST段抬高型心肌梗死(STEMI)患者住院期间发生心力衰竭的预测价值。方法前瞻性连续收集2010年11月至2011年9月住院的STEMI患者120例。入院后测定血浆CST浓度,收集临床资料。依据CST浓度四分位数间距分为≤74.72、74.73~79.67、79.68—84.21、≥84.22ng/L4个组,每组30例,比较临床特征、治疗过程。依据患者临床特征,判断有无心力衰竭,并进行Killip分级,KillipⅠ级(n=68),KillipⅡ级(n=23),KillipⅢ级(n=18),KillipⅣ级(n=11),比较各组CST、去甲肾上腺素(NE)、氨基末端B型利钠肽前体(NT—proBNP)浓度。通过Spearman秩相关分析CST与左心室射血分数(LVEF),CST与NT—proBNP的关系;用多因素logistic回归筛选影响住院期间STEMI患者发生心力衰竭的相关因素;用受试者工作特征(ROC)曲线评价CST和NT-proBNP对住院期间STEMI患者发生心力衰竭的预测价值。结果4组在性别、住院天数、既往吸烟史、高血压病史、心肌梗死史,入院时血压、心率、血糖、血脂水平以及早期再灌注等指标差异均无统计学意义(P〉0.05)。在年龄,既往患糖尿病史、心绞痛病史,体质指数,白细胞计数,胱抑素-C,高敏C反应蛋白及利尿剂应用随着CST浓度升高而明显增加(P〈0.05)。LVEF随着CST浓度升高而明显降低(P=0.005),NE、NT—proBNP浓度随着CST浓度升高明显升高(P〈0.01)。STEMI患者伴心力衰竭时,CST、NT-proBNP浓度显著高于STEMI不伴心力衰竭的患者(P〈0.01)。NE浓度水平在两组问差异无统计学意义(P〉0.05)。随着心功能的恶化,CST、NE、NT—proBNP浓度逐渐升高(P〈0.05)。Spearman秩相关分析显示CST与LVEF呈显著负相关(t=-0.923,P〈0.001);CST与NT—proBNP呈显著正相关(rs=0.884,P〈0.001)。多因素logistic回归分析显示CST是住院期间STEMI患者发生心力衰竭的独立危险因素(OR=1.125,95%CI:1.056~1.198,P〈0.001),其预测住院期间心力衰竭发生的ROC曲线下面积为0.777(P〈0.01),当血浆CST=77.29ng/L时预测价值最高,敏感度和特异度分别为92.8%和70.6%。NT—proBNP预测住院期间STEMI患者发生心力衰竭的ROC曲线下面积为0.874。结论CST是STEMI患者住院期间心力衰竭发生的独立危险因素,能有效预测STEMI患者住院期间心力衰竭的发生。 Objective To determine whether circulating level of catestatin (CST) could provide prognostic information independently of conventional risk markers for the development of in-hospital heart failure in patients with ST-segment elevation myocardial infarction (STEMI). Methods The data of 120 STEMI patients (mean age: 61 years, 73% male) were collected fi'om the Second Hospital of Shanxi Medical University and Taiyuan Central Hospital between November 2010 and September 2011. The patients were categorized into 4 groups according to CST (ng/L) quartile: ≤74.72, 74. 73 -79. 67, 79. 68 -84. 21 and ≥84. 22 ng/L. Clinical features, therapeutic approaches were compared among groups. The patients were also grouped according to Killip class : Killip level Ⅰ ( n = 68) , Killip level Ⅱ ( n = 23 ) , Killip level Ⅲ(n = 18), Killip level Ⅳ (n = 11 ). CST, NE and NT-proBNP were compared among groups. The Spearma rank correlation and multivariate logistic regression analysis were applied to determine the association between risk factors and in-hospital heart failure. Receiver-operator characteristic (ROC) curve was performed to evaluate the power of CST and NT-proBNP on predicting in-hospital heart failure. Results Gender, hospital days, past history of smoking, hypertension, myocardial infarction, CK-MB peak level, TnI peak level, heart rate, blood pressure, blood glucose, blood lipid levels on admission and early reperfusion therapy were similar among groups. Patients with higher CST values were more likely to be older, to have lower body mass index, to have higher white blood cell count, CysC, hs-CRP, NE, NT-proBNP, past history of angina, diabetes mellitus, being diuretic users, and to have a lower ejection fraction ( all P 〈 0.05 ). Higher CST levels were also associated with increased risk of heart failure ( P 〈 0. 05 ). In proportion with the deterioration of the cardiac function, CST, NE, NT-proBNP concentration gradually increased ( all P 〈 0. 05 ). Spearman rank correlation analysis showed that the CST was negatively correlated with LVEF (rs = -0. 923, P 〈 0. 001 ) and positivey correlated with NT-proBNP ( rs = 0. 884, P 〈 0. 001 ), After multivariate adjustment, CST remained to be an independent risk factor for the development of in-hospital heart failure( OR = 1. 125,95% CI: 1. 056 - 1. 198 ;P 〈 0. 001 ). The area under the ROC curve of CST and NT-proBNP was 0. 777 and 0. 874. Using CST = 77.29 ng/L as a cut-off value, the sensitivity was 92. 8% and specificity was 70. 6% for predicting the development of in-hospital heart failure. Conclusion The plasma CST level is an independent predictor for the development of in-hospital heart failure in patients with STEMI.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2012年第11期914-919,共6页 Chinese Journal of Cardiology
基金 太原市中心医院科研项目(1120102)
关键词 心肌梗死 心力衰竭 儿茶酚胺类 抑素类 Myocardial infarction Heart failure Catecholamines Chalones
  • 相关文献

参考文献4

二级参考文献63

  • 1谢洪智,朱文玲.重组人脑利钠肽和硝酸甘油治疗急性失代偿性心力衰竭疗效和安全性的随机、开放、平行对照的多中心临床研究[J].中华心血管病杂志,2006,34(3):222-226. 被引量:228
  • 2中华医学会心血管病学分会 中华心血管病杂志编辑委员会.β肾上腺素能受体阻滞剂在心血管疾病应用的专家共识[J].中华心血管病杂志,2009,37:195-209.
  • 3中华医学会心血管病学分会 中华心血管病杂志编辑委员会.慢性心力衰竭诊断治疗建议.中华心血管病杂志,2007,35(12):1076-1095.
  • 4Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26: 384-416.
  • 5Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC ( HFA ) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J, 2008, 29 : 2388-2442.
  • 6Hunt SA, American College of Cardiology, American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure ). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart fa/lure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol, 2005, 46: e1-e82.
  • 7Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Aduks: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines : developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation, 2009, 119: 1977-2016.
  • 8Liang KV, Williams AW, Greene EL, et al. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med, 2008, 36(1 Suppl) : S75-S88.
  • 9Chen D, Assad-Kottner C, Orrego C, et al. Cytokines and acute heart failure. Crit Care Med, 2008, 36(1 Suppl) : S9-S16.
  • 10Chen AA, Wood MJ, Krauser DG, et al. NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy. Eur Heart J, 2006, 27 : 839-845.

共引文献2943

同被引文献126

引证文献18

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部